1. |
Neumann UP, Guckelberger O, Langrehr JM, et al. Impact of human leukocyte antigen matching in liver transplantation [J]. Transplantation, 2003; 75(1)∶132.
|
2. |
Kasahara M, Kiuchi T, Uryuhara K, et al. Role of HLA compatibility in pediatric livingrelated liver transplantation [J]. Transplantation, 2002; 74(8)∶1175.
|
3. |
Sieders E, Hepkema BG, Peeters PM, et al. The effect of HLA mismatches, shared crossreactive antigen groups, and shared HLADR antigens on the outcome after pediatric liver transplantation [J]. Liver Transpl, 2005; 11(12)∶1541.
|
4. |
Campos J, Quijano Y, Franco A, et al. Beneficial effects of HLA class Ⅱ incompatibility in living donor liver transplantation [J]. Transplant Proc, 2003; 35(5)∶1888.
|
5. |
Doran TJ, Geczy AF, Painter D, et al. A large, single center investigation of the immunogenetic factors affecting liver transplantation [J]. Transplantation, 2000; 69(7)∶1491.
|
6. |
Muro M, Marin L, Miras M, et al. Liver recipients harbouring antidonor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre [J]. Transpl Immunol, 2005; 14(2)∶91.
|
7. |
Matinlauri IH, Hockerstedt KA, Isoniemi HM. Equal overall rejection rate in pretransplant flowcytometric crossmatch negative and positive adult recipients in liver transplantation [J]. Clin Transplant, 2005; 19(5)∶626.
|
8. |
Donaldson PT, Alexander GJ, O’Grady J, et al. Evidence for an immune response to HLA class Ⅰ antigens in the vanishingbileduct syndrome after liver transplantation [J]. Lancet, 1987; 1(8539)∶945.
|
9. |
Lobo PI, Spencer C, Douglas MT, et al. The lack of longterm detrimental effects on liver allografts caused by donorspecific antiHLA antibodies [J]. Transplantation, 1993; 55(5)∶1063.
|
10. |
Karuppan S, Ericzon BG, Moller E. Relevance of a positive crossmatch in liver transplantation [J]. Transpl Int, 1991; 4(1)∶18.
|
11. |
Katz SM, Kimball PM, Ozaki C, et al. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients [J]. Transplantation, 1994; 57(4)∶616.
|
12. |
Saidman SL, Duquesnoy RJ, Demetris AJ, et al. Combined liverkidney transplantation and the effect of preformed lymphocytotoxic antibodies [J]. Transpl Immunol, 1994; 2(1)∶ 61.
|
13. |
Girnita AL, Webber SA, Zeevi A. AntiHLA alloantibodies in pediatric solid organ transplantation [J]. Pediatric Transplant, 2006; 10(2) ∶146.
|
14. |
Neumann UP, Langrehr JM, Naumann U, et al. Impact of HLAcompatibilities in patients undergoing liver transplantation for HBVcirrhosis [J]. Clin Transplant, 2002; 16(2)∶122.
|
15. |
Kimball P, Stravitz T. DR antigens influence graft outcome and HCV recurrence after liver transplantation [J]. Transplant Proc, 2005; 37(2)∶1099.
|
16. |
Manez R, White LT, Linden P, et al. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation [J]. Transplantation, 1993; 55(5)∶1067.
|
17. |
Markus BH, Duquesnoy RJ, Gordon RD, et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? [J]. Transplantation, 1988; 46(3)∶372.
|